Zobrazeno 1 - 10
of 131
pro vyhledávání: '"Biljana Horn"'
Autor:
Emilie J. Lynch, Autumn Citta, Constance Alford, John A. Ligon, Mansi Dalal, Paul Castillo, Biljana Horn, Natalie Dotson, Giselle Moore-Higgs, Jordan Milner
Publikováno v:
Leukemia Research Reports, Vol 22, Iss , Pp 100472- (2024)
Patients who receive allogeneic hematopoietic stem cell transplantation (alloHSCT) are at risk for developing persistent thrombocytopenia. Here, we describe treatment with avatrombopag, a thrombopoietin receptor agonist, in a pediatric patient with c
Externí odkaz:
https://doaj.org/article/c0c4899820df420ea9a64953e8ed8546
Autor:
Rui Zhang, Juan Xiao, Yuan Sun, Sanfang Tu, Yuhua Li, Leping Zhang, Yifei Cheng, Song Xue, Yongping Zhang, Bin Wang, Huyong Zheng, Nobuhiro Nishio, Yoshiyuki Takahashi, Seiji Kojima, Yingying Wang, Biljana Horn, Lung-Ji Chang
Publikováno v:
Frontiers in Hematology, Vol 2 (2023)
IntroductionAllogeneic hematopoietic stem cell transplantation (allo-HCT) is a standard treatment for relapsed/refractory B-cell acute lymphoblastic leukemia (r/r B-ALL). However, about 30-40% of patients still relapse after HCT. Chimeric antigen rec
Externí odkaz:
https://doaj.org/article/174eecda57594ec196b5b82d0c79159f
Publikováno v:
Kidney Medicine, Vol 3, Iss 6, Pp 1086-1090 (2021)
Chimeric antigen receptor T (CAR-T) cell treatment is a rapidly emerging therapy for relapsed/refractory hematologic malignancies. Although cytokine release syndrome is a common complication, a concomitant development of biopsy-proven collapsing glom
Externí odkaz:
https://doaj.org/article/35befe6ee7f34e9ea0841f25521eb3bf
Autor:
Braden Olsen, Jessica Bodea, Angela Garcia, Kristen Beebe, Courtney Campbell, Carly Schwalbach, Dana Salzberg, Holly Miller, Roberta Adams, Lucia Mirea, Paul Castillo, Biljana Horn, Sandhya Bansal, Thalachallour Mohanakumar, Alexander Ngwube
Publikováno v:
Frontiers in Pediatrics, Vol 10 (2022)
Vitamin D deficiency is prevalent in pediatric patients presenting for hematopoietic stem cell transplantation (HSCT) and has been linked to poor clinical outcomes. Using the data from a randomized control trial, in this paper we explore the effects
Externí odkaz:
https://doaj.org/article/843e3963374d4189826745510bb40f68
Autor:
Jordan T. Brooks, Belen P. Solans, Ying Lu, Sandhya Kharbanda, Christopher C. Dvorak, Nahal Lalefar, Susie Long, Ashish O. Gupta, Biljana Horn, Jatinder K. Lamba, Liusheng Huang, Beth Apsel-Winger, Ron J. Keizer, Rada Savic, Janel Long-Boyle
Publikováno v:
Pharmaceutics, Vol 14, Iss 11, p 2462 (2022)
Fludarabine is a nucleoside analog with antileukemic and immunosuppressive activity commonly used in allogeneic hematopoietic cell transplantation (HCT). Several fludarabine population pharmacokinetic (popPK) and pharmacodynamic models have been publ
Externí odkaz:
https://doaj.org/article/d21a0c32b48140698c426dacb4569d19
Autor:
Hisham Abdel-Azim, Troy C. Quigg, Jemily Malvar, Elizabeth Gourdine, Neena Kapoor, Amy K. Keating, Kris Michael Mahadeo, Jodi L. Skiles, Dana Salzberg, Lisa M. Madden, Rachel Phelan, Nahal Lalefar, Emi H. Caywood, Rabi Hanna, Shalini Shenoy, Heather E. Stefanski, Biljana Horn, Benjamin Oshrine, Christine S. Higham, Ulrich A. Duffner, Joseph H. Chewning, Jason Law, Niketa C. Shah, Jeffrey S. Huo, Leslie E. Lehmann, Ibrahim Ahmed, Barbara Bambach, Michael A Pulsipher
Publikováno v:
Transplantation and Cellular Therapy. 29:S94-S96
Autor:
Ally Fraser, Paul Castillo, Erika Cascio, Giselle Moore‐Higgs, Nosha Farhadfar, John Fort, William Slayton, Jatinder Lamba, Biljana Horn
Publikováno v:
Pediatric Blood & Cancer. 70
Autor:
Trisha Larkin, Reema Kashif, Abdelrahman H. Elsayed, Beate Greer, Karna Mangrola, Roya Raffiee, Nam Nguyen, Vivek Shastri, Biljana Horn, Jatinder K. Lamba
Publikováno v:
JCO Precision Oncology.
PURPOSE Acute lymphoblastic leukemia (ALL) is the most prevalent cause of childhood cancer and requires a long course of therapy consisting of three primary phases with interval intensification blocks. Although these phases are necessary to achieve r
Publikováno v:
Kidney Medicine
Kidney Medicine, Vol 3, Iss 6, Pp 1086-1090 (2021)
Kidney Medicine, Vol 3, Iss 6, Pp 1086-1090 (2021)
Chimeric antigen receptor T (CAR-T) cell treatment is a rapidly emerging therapy for relapsed/refractory hematologic malignancies. Although cytokine release syndrome is a common complication, a concomitant development of biopsy-proven collapsing glom
Autor:
David Crawford, Jorge Galvez Silva, Deepak Chellapandian, Michael Joyce, Reema Kashif, Jordan Milner, Mansi Dalal, Kevin O. McNerney, Jessica Cline, John Fort, Paul Castillo, John A Ligon, Warren Alperstein, Edward Ziga, Shu Wang, Biljana Horn
Publikováno v:
Transplantation and Cellular Therapy. 29:S299-S300